Д.Медведев.Рабочая встреча с Т.Голиковой.06.11.09.Part 1

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
2,432
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Nov 12, 2009

Beginning of Meeting with Minister of Healthcare and Social Development Tatyana Golikova.Part 1
November 6, 2009
Gorki, Moscow Region

Рабочая встреча с Министром здравоохранения и социального развития Татьяной Голиковой
6 ноября 2009 года
Московская область, Горки

PRESIDENT OF RUSSIA DMITRY MEDVEDEV: Lets discuss the situation with medicines. Currently, we are dealing with this issue at various levels including the Commission for Modernisation and Technological Development of Russia's Economy. We intend to pay special attention to developing our pharmaceutical industry. One of our priorities would be drafting a list of strategically significant medicines that must be produced domestically to fully meet our internal demand. That would guarantee our national independence of foreign suppliers.

I have given relevant instructions. Please report on what has been accomplished. We will review other matters afterwards.

MINISTER OF HEALTHCARE AND SOCIAL DEVELOPMENT TATYANA GOLIKOVA: Mr President, we initiated drafting a bill on medicines market prior to the establishment of the Commission [for Modernisation and Technological Development of Russia's Economy] and your instructions on determining the list of strategically important medicines. Once the draft law was prepared, it was submitted to the Government of the Russian Federation which will examine it shortly.

I should say the law itself was a difficult one, and the drafting process was not easy, as it involved redrafting or amending numerous laws and regulations pertaining to the medicines market, including government resolutions, orders by the Ministry of Healthcare and Social Development, and everything else regulating supply of domestic or imported medicines to the Russian market.

DMITRY MEDVEDEV: What kind of amendments have been introduced?

TATYANA GOLIKOVA: I would say that the first and perhaps one of the most important amendments was a simplified medicines registering procedure which until now has been the major problem for all.

DMITRY MEDVEDEV: Indeed, we hear complaints about it all the time.

TATYANA GOLIKOVA: In this regard, I should mention that the draft law specifies in detail the mechanism of the [registration] procedure and the duties and responsibilities of everyone involved therewith. Whats most important is that from now on the law will clearly regulate the various procedures which currently lack proper transparency.

(The Minister further reported in detail on specific mechanisms of medicines examination, approval and government registration.)

I would like to move on to a subject of composing the list of vitally important and most essential medicines. The last time such a list was revised in 2007. Even though it is to be revised on the annual basis, that was not the case, it is therefore imperative now to accomplish its overall revision in line with the legislative amendments and your instructions.

DMITRY MEDVEDEV: How many medicines do we have today on that list?

TATYANA GOLIKOVA: At the moment it contains 658 international unpatented medicines and 1,000 brand name medicines. But the major problem with the list is lack of any straightforward principles for medicines selection and acceptance. Given that the medicines on this list must meet certain parameters of standard medical treatment, it must be crystal clear how and why the medicines were put on that list, how efficient they are and what advantages they offer.

Respective analysis will be completed shortly. By now, we have reduced this list to 488 medicines, leaving only the vital ones, as well as effective medicines produced domestically. Based on our provisional list, we finalised suggestions regarding strategically important medicines. Out of the 488 international unpatented brand names, 165 medicines are not manufactured in Russia. Unfortunately, these 165 medicines include ones that can improve the mortality and morbidity rates in Russia.

(Then, Ms Golikova gave a detailed explanation of the criteria for selecting strategically important medicines for the list.)

http://www.kremlin.ru

  • likes, 2 dislikes

Link to this comment:

Share to:

Top Comments

  • Пизда тупая

  • Какая у неё пластика .. кошка...

see all

All Comments (17)

Sign In or Sign Up now to post a comment!
  • Голикова будет сосать в аду раскалённый хуй властелина тьмы.

  • @smolnykov хуёшка

  • гном и крыса. закон уродски непродуманный.

  • заткнула бы свою гузку куриную, курица общипанная

  • заткнула бы свою гузку куриную

  • Так она в министры наверно через минеты пробивалась.

  • Я ваши рты трахал бы, шакалы!

    Голикова отличная девушка!

  • пиздоголикова

  • сыт кагда страшно

Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more